Loading…

Gfi1, a transcriptional repressor, inhibits the induction of the T helper type 1 programme in activated CD 4 T cells

A transcriptional repressor Gfi1 promotes T helper type 2 (Th2) cell development and inhibits Th17 and inducible regulatory T‐cell differentiation. However, the role of Gfi1 in regulating Th1 cell differentiation and the Th1‐type immune response remains to be investigated. We herein demonstrate that...

Full description

Saved in:
Bibliographic Details
Published in:Immunology 2016-04, Vol.147 (4), p.476-487
Main Authors: Suzuki, Junpei, Maruyama, Saho, Tamauchi, Hidekazu, Kuwahara, Makoto, Horiuchi, Mika, Mizuki, Masumi, Ochi, Mizuki, Sawasaki, Tatsuya, Zhu, Jinfang, Yasukawa, Masaki, Yamashita, Masakatsu
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A transcriptional repressor Gfi1 promotes T helper type 2 (Th2) cell development and inhibits Th17 and inducible regulatory T‐cell differentiation. However, the role of Gfi1 in regulating Th1 cell differentiation and the Th1‐type immune response remains to be investigated. We herein demonstrate that Gfi1 inhibits the induction of the Th1 programme in activated CD 4 T cells. The activated Gfi1 ‐deficient CD 4 T cells spontaneously develop into Th1 cells in an interleukin‐12‐ and interferon‐ γ ‐independent manner. The increase of Th1‐type immune responses was confirmed in vivo in Gfi1 ‐deficient mice using a murine model of nickel allergy and delayed‐type hypersensitivity (DTH). The expression levels of Th1‐related transcription factors were found to increase in Gfi1 ‐deficient activated CD 4 T cells. Tbx21, Eomes and Runx2 were identified as possible direct targets of Gfi1. Gfi1 binds to the Tbx21 , Eomes and Runx2 gene loci and reduces the histone H3K4 methylation levels in part by modulating Lsd1 recruitment. Together, these findings demonstrate a novel regulatory role of Gfi1 in the regulation of the Th1‐type immune response.
ISSN:0019-2805
1365-2567
DOI:10.1111/imm.12580